- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03640104
Individualized Dietary Intervention in Breastfeeding Women: Body Weight and Vitamin A Stores
April 26, 2021 updated by: Verónica López Teros, PhD, Universidad de Sonora
Effect of an Individualized Dietary Intervention on the Body Composition and Vitamin A Status of Breastfeeding Women
Breast milk is the best food during the first 6mo of life because it offers multiple benefits for the mother-infant pair.
An inadequate maternal diet during pregnancy can lead to excess weight gain, leading to negative health consequences for the dyad.
In Mexico, an excess of body weight coexists with micronutrient deficiencies (double burden of malnutrition).
Low vitamin A concentration has been observed in northwest Mexico, which can affect the human milk composition and increase the risk of VAD in breastfed babies.
An individualized dietary intervention in the lactating woman will reduce body weight and improve vitamin A status.
The objective is to assess the effect of an individualized dietary intervention during 3 months postpartum on body composition and vitamin A status of lactating women.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This protocol was approved by the Bioethics Committee of the Department of Medicine and Health Sciences of Universidad de Sonora.
A randomized controlled trial will be carried out and participant women will be assigned by simple randomization 1:1 to either the intervention or control group, upon signing an informed consent.
At baseline (2wk postpartum), anthropometric (weight, height, mid upper-arm circumference and triceps skinfold thickness) and body composition (DXA) measurements as well as the assessment of vitamin A status (serum and breastmilk retinol and the modified relative dose response) will be performed.
The control group will receive only recommendations for a healthy diet in accordance with international standards and will be followed up every month to promote adherence and to assess their nutritional status.
On the other hand, the intervention group will receive an individualized macronutrient meal equivalent menu, with nutritional consultations every two weeks.
The dietary plan will include 1-1.5 g/kg body weight protein, 30% total fat (preferably mono and polyunsaturated fatty acids), and vitamin A sources (1300 RAE).
After 3 months of intervention are completed, baseline measurements will be repeated.
Statistical analysis will include descriptive stats and comparisons between groups (t-tests), significance will be defined as P < 0.05.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sonora
-
Hermosillo, Sonora, Mexico, 83000
- Universidad de Sonora
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- BMI ≥ 25
- Predominant breastfeeding
- Signed Informed Consent
Exclusion Criteria:
- Multiparity
- Alcohol, drugs, tobacco intake
- Use of dietary supplements
- Active infection (C reactive protein > 6mg/L)
- External nutritional counseling
- Pregnancy during the study period
- Liver disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention-Nutrition guidelines
Subjects will receive an individualized dietary plan according to their nutritional status, socioeconomic and cultural preferences.
Protein intake 1-1.5g/kg body weight; 30% fat (mono and polyunsaturated fatty acids), vitamin A sources (1300 RAE).
Each subject will have 7 interchangeable options for every meal time, all equivalent in macronutrient content, and every two weeks a new menu will be provided by a nutritionist.
|
Subjects will receive an individualized dietary plan according to their nutritional status, socioeconomic and cultural preferences.
Protein intake 1-1.5g/kg body weight; 30% fat (mono and polyunsaturated fatty acids), vitamin A sources (1300 RAE).
Each subject will have 7 interchangeable options for every meal time, all equivalent in macronutrient content, and every two weeks a new menu will be provided by a nutritionist.
|
Other: Nutrition Guidelines
Participants will receive general nutritional recommendations according to international standards
|
Nutritional recommendations based on international guidelines
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Body weight
Time Frame: Baseline and 3 months after enrollment
|
Difference in change (between baseline and final body weight within groups) between the intervention and control group, respectively
|
Baseline and 3 months after enrollment
|
Vitamin A liver stores
Time Frame: Baseline and 3 months after enrollment
|
Stores are calculated as the DR/R ratio.
The outcome will be calculated as the difference in change (between baseline and final VA stores within groups) between the intervention and control group, respectively
|
Baseline and 3 months after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body fat mass
Time Frame: Baseline and 3 months after enrollment
|
Difference in change (between baseline and final body fat mass within groups) between the intervention and control group, respectively
|
Baseline and 3 months after enrollment
|
Retinol
Time Frame: Baseline and 3 months after enrollment
|
Difference in change (between baseline and final retinol concentration within groups) between the intervention and control group, respectively
|
Baseline and 3 months after enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Veronica Lopez-Teros, Dr, Universidad de Sonora
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2018
Primary Completion (Actual)
February 7, 2020
Study Completion (Actual)
February 7, 2020
Study Registration Dates
First Submitted
August 17, 2018
First Submitted That Met QC Criteria
August 17, 2018
First Posted (Actual)
August 21, 2018
Study Record Updates
Last Update Posted (Actual)
April 28, 2021
Last Update Submitted That Met QC Criteria
April 26, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VLT-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin A Deficiency
-
SourseCitruslabsActive, not recruitingMood | Energy Supply; Deficiency | B12 Deficiency VitaminUnited States
-
Boston UniversityCompletedVitamin D Deficiency | Vitamin E Deficiency | Hypovitaminosis AUnited States
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustEnrolling by invitationIron Deficiency (Without Anemia) | B12 Deficiency VitaminUnited Kingdom
-
Kansas State UniversityNational Institute for Medical Research, Tanzania; United States Department... and other collaboratorsCompletedAnemia, Iron-Deficiency | Deficiency, Vitamin A
-
Newcastle UniversityBill and Melinda Gates Foundation; Institute of Nutrition of Central America... and other collaboratorsUnknownVitamin A Deficiency | Vitamin A Toxicity | Hypervitaminosis AGuatemala, United Kingdom
-
Fatih Sultan Mehmet Training and Research HospitalActive, not recruitingVitamin D Deficiency | Lipedema | B12 Deficiency VitaminTurkey
-
Nottingham University Hospitals NHS TrustNorthern Care Alliance NHS Foundation Trust; Barts & The London NHS Trust; University... and other collaboratorsNot yet recruitingParesthesia | Neurologic Symptoms | B12 Deficiency Vitamin | Nitrous Oxide Abuse | Subacute Combined Cord Degeneration
-
University of Wisconsin, MadisonNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedVitamin A Deficiency | Vitamin A ToxicityUnited States
-
University of California, DavisPenn State University; University of Ghana; Newcastle University; Helen Keller...CompletedAnemia | Dietary Habits | Iron Deficiency | Vitamin A Deficiency | Vitamin B 12 Deficiency | Folate Deficiency | Zinc DeficiencyGhana
Clinical Trials on Intervention-Nutrition guidelines
-
Mansoura UniversityNot yet recruitingEnteral Nutrition
-
Academy of Nutrition and DieteticsFresenius AG; Davita Clinical ResearchRecruitingChronic Kidney DiseasesUnited States
-
Seattle Institute for Biomedical and Clinical ResearchNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University of Washington and other collaboratorsCompletedAlcoholism | Stress Disorders, Post-TraumaticUnited States
-
Rigshospitalet, DenmarkUniversity of Copenhagen; European Society for Clinical Nutrition and Metabolism and other collaboratorsCompletedCritical Illness | Mechanical Ventilation | Muscle Wasting | Intensive Care (ICU) Myopathy | Loss of Physical FunctionDenmark
-
University of Ontario Institute of TechnologyCanadian Institutes of Health Research (CIHR)RecruitingNutrition, HealthyCanada
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingOropharynx Cancer | Oral Cavity Cancer | Larynx Cancer | Hypopharynx CancerUnited States
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
University of AlbertaAlberta Heritage Foundation for Medical ResearchCompletedOsteoporosis | Wrist FracturesCanada
-
McGill UniversityMcMaster University; University of Sydney; Institut National du Sport du QuebecRecruiting
-
Vanderbilt UniversityNestlé; Lance Armstrong FoundationCompleted